Natural history of colonic polyposis in young patients with familial adenomatous polyposis

Burt, 2005, Genetic testing for inherited colon cancer, Gastroenterology, 128, 1696, 10.1053/j.gastro.2005.03.036 Kerr, 2013, APC germline mutations in individuals being evaluated for familial adenomatous polyposis: a review of the Mayo Clinic experience with 1591 consecutive tests, J Mol Diagn, 15, 31, 10.1016/j.jmoldx.2012.07.005 Heiskanen, 2000, Impact of screening examinations on survival in familial adenomatous polyposis, Scand J Gastroenterol, 35, 1284, 10.1080/003655200453638 Jarvinen, 1992, Epidemiology of familial adenomatous polyposis in Finland: impact of family screening on the colorectal cancer rate and survival, Gut, 33, 357, 10.1136/gut.33.3.357 Olsen, 2003, Female fecundity before and after operation for familial adenomatous polyposis, Br J Surg, 90, 227, 10.1002/bjs.4082 Tudyka, 2012, Surgical treatment in familial adenomatous polyposis, Ann Gastroenterol, 25, 201 Andrews, 2007, Impact of familial adenomatous polyposis on young adults: quality of life outcomes, Dis Colon Rectum, 50, 1306, 10.1007/s10350-007-0259-9 Syngal, 2015, ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes, Am J Gastroenterol, 110, 223, 10.1038/ajg.2014.435 Nieuwenhuis, 2007, Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature, Crit Rev Oncol Hematol, 61, 153, 10.1016/j.critrevonc.2006.07.004 Cruz-Correa, 2002, Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study, Gastroenterology, 122, 641, 10.1053/gast.2002.31890 Lynch, 2010, The safety and efficacy of celecoxib in children with familial adenomatous polyposis, Am J Gastroenterol, 105, 1437, 10.1038/ajg.2009.758 Steinbach, 2000, The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis, N Engl J Med, 342, 1946, 10.1056/NEJM200006293422603 Lynch, 2016, An international randomised trial of celecoxib versus celecoxib plus difluoromethylornithine in patients with familial adenomatous polyposis, Gut, 65, 286, 10.1136/gutjnl-2014-307235 Burke, 2017, Children's International Polyposis (CHIP) study: a randomized, double-blind, placebo-controlled study of celecoxib in children with familial adenomatous polyposis, Clin Exp Gastroenterol, 10, 177, 10.2147/CEG.S121841 Lynch, 2016, Chemoprevention of familial adenomatous polyposis, Fam Cancer, 15, 467, 10.1007/s10689-016-9901-9 Niv, 1994, Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy, Gastroenterology, 107, 854, 10.1016/0016-5085(94)90136-8 Lynch, 1995, Rectal cancer after prolonged sulindac chemoprevention. A case report, Cancer, 75, 936, 10.1002/1097-0142(19950215)75:4<936::AID-CNCR2820750407>3.0.CO;2-Q Giardiello, 1998, Prostaglandin levels in human colorectal mucosa: effects of sulindac in patients with familial adenomatous polyposis, Dig Dis Sci, 43, 311, 10.1023/A:1018898120673 Miyoshi, 1992, Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene, Hum Mol Genet, 1, 229, 10.1093/hmg/1.4.229 Scott, 2004, Germline missense changes in the APC gene and their relationship to disease, Hered Cancer Clin Pract, 2, 81, 10.1186/1897-4287-2-2-81 Charames, 2008, A large novel deletion in the APC promoter region causes gene silencing and leads to classical familial adenomatous polyposis in a Manitoba Mennonite kindred, Hum Genet, 124, 535, 10.1007/s00439-008-0579-4 De Rosa, 2007, Alternative splicing and nonsense-mediated mRNA decay in the regulation of a new adenomatous polyposis coli transcript, Gene, 395, 8, 10.1016/j.gene.2006.10.027 Lynch, 2016, A proposed staging system and stage-specific interventions for familial adenomatous polyposis, Gastrointest Endosc, 84, 115, 10.1016/j.gie.2015.12.029 da Luz Moreira, 2009, The evolution of prophylactic colorectal surgery for familial adenomatous polyposis, Dis Colon Rectum, 52, 1481, 10.1007/DCR.0b013e3181ab58fb